Hidradenitis Suppurativa - Pipeline Review, H2 2016 - Global Markets Direct - Market Research

Hidradenitis Suppurativa - Pipeline Review, H2 2016

Hidradenitis Suppurativa - Pipeline Review, H2 2016 - Global Markets Direct - Market Research
Hidradenitis Suppurativa - Pipeline Review, H2 2016
Published Jul 13, 2016
63 pages — Published Jul 13, 2016
Price US$ 2,000.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Hidradenitis Suppurativa - Pipeline Review, H2 2016, provides an overview of the Hidradenitis Suppurativa pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hidradenitis Suppurativa, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Hidradenitis Suppurativa and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Hidradenitis Suppurativa
- The report reviews pipeline therapeutics for Hidradenitis Suppurativa by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Hidradenitis Suppurativa therapeutics and enlists all their major and minor projects
- The report assesses Hidradenitis Suppurativa therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Hidradenitis Suppurativa

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Hidradenitis Suppurativa
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by und

  
Source:
Document ID
GMDHC8225IDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables41
  List of Figures41
Introduction51
  Global Markets Direct Report Coverage51
Hidradenitis Suppurativa Overview61
Therapeutics Development71
  Pipeline Products for Hidradenitis Suppurativa Overview71
Hidradenitis Suppurativa Therapeutics under Development by Companies81
Hidradenitis Suppurativa Pipeline Products Glance93
  Late Stage Products91
  Clinical Stage Products101
  Early Stage Products111
Hidradenitis Suppurativa Products under Development by Companies121
Hidradenitis Suppurativa Companies Involved in Therapeutics Development136
  Cellceutix Corporation131
  Celtaxsys, Inc.141
  Delenex Therapeutics AG151
  Johnson &Johnson161
  Novartis AG171
  Sandoz International GmbH181
Hidradenitis Suppurativa Therapeutics Assessment199
  Assessment by Monotherapy Products191
  Assessment by Target202
  Assessment by Mechanism of Action222
  Assessment by Route of Administration242
  Assessment by Molecule Type262
Drug Profiles2831
  acebilustat Drug Profile283
  adalimumab biosimilar Drug Profile311
  adalimumab biosimilar Drug Profile321
  brilacidin tetrahydrochloride Drug Profile339
  CJM-112 Drug Profile421
  DLX-105 Drug Profile433
  DLX-2751 Drug Profile461
  Small Molecule to Disrupt Cell Membrane for Hidradenitis Suppurativa Drug Profile471
  ustekinumab Drug Profile486
  Xilonix Drug Profile545
Hidradenitis Suppurativa Dormant Projects591
Hidradenitis Suppurativa Discontinued Products601
Hidradenitis Suppurativa Product Development Milestones611
  Featured News &Press Releases611
    Sep 11, 2014: Delenex Announces New Clinical Data611
Appendix622
  Methodology621
  Coverage621
  Secondary Research621
  Primary Research621
  Expert Panel Validation621
  Contact Us621
  Disclaimer631

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Hidradenitis Suppurativa - Pipeline Review, H2 2016" Jul 13, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Hidradenitis-Suppurativa-Pipeline-Review-H2-2016-2088-16160>
  
APA:
Global Markets Direct - Market Research. (2016). Hidradenitis Suppurativa - Pipeline Review, H2 2016 Jul 13, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Hidradenitis-Suppurativa-Pipeline-Review-H2-2016-2088-16160>
  
US$ 2,000.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.